Nova Eye Medical

IGC 2024 Roundtable Discussion

Analisa Arosemena, MD; Rachel G. Simpson, MD; Larissa Camejo, MD; Shivani Kamat, MD; Mary Qiu, MD; Christine Funke, MD; and Sahar Bedrood, MD, PhD

Show Description +

Nova Eye Medical partnered with leading glaucoma specialists on a panel at the Interventional Glaucoma Consortium (IGC) 2024 to address insights on canaloplasty and the iTrack™ Advance with the next generation of ophthalmologists.

Posted: 4/21/2025

Up Next

Name: IGC 2024 Roundtable Discussion
Uploaded: 2025-04-21T15:11:52+00:00
Description: Nova Eye Medical partnered with leading glaucoma specialists on a panel at the Interventional Glaucoma Consortium (IGC) 2024 to address insights on canaloplasty and the iTrack™ Advance with the next generation of ophthalmologists.

Perfecting your Canaloplasty Technique

Mary Qiu, MD

What is Canaloplasty?

Shivani Kamat, MD

A Spotlight on the iTrack™ Advance

Larissa Camejo, MD

Canaloplasty: the Importance of OVD Volume and Pressure

Christine Funke, MD

Positioning Canaloplasty in the Glaucoma Treatment Paradigm

Sahar Bedrood, MD, PhD

Canaloplasty with the iTrack Advance

Sahar Bedrood, MD, PhD

Glaucoma: A Deep Dive on the Comprehensive Mechanism of Canaloplasty

Robert Noecker, MD

An Introduction to iTrack Advance

Manjool Shah, MD; and Lyle Newball, MD

Advantages of the iTrack Advance

Iqbal Ike K. Ahmed, MD, FRCSC; and Ticiana De Francesco, MD

Benefits of Canaloplasty in the Glaucoma Treatment Paradigm

Analisa Arosemena, MD

Advancing Canaloplasty to the Next Level

The Molteno3 Glaucoma Drainage Device

iTrack at ASCRS 2022

The Evolution of Canaloplasty

Arsham Sheybani, MD; and Murray Johnstone, MD

Misconceptions Surrounding the Trabecular Meshwork

Arsham Sheybani, MD; and Murray Johnstone, MD

iTrack Roundtable: the Role of Canaloplasty in Pseudophakic Patients

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Ahmad A. Aref, MD, MBA; James T. Murphy, MD; and David Lubeck, MD

iTrack Roundtable: Versatility of Canaloplasty in Clinical Practice

iTrack Roundtable: What is the Role of Canaloplasty in Patients With Severe Glaucoma?

iTrack Roundtable: Defining Postoperative Success

Spare or Tear? Pearls for the Trabecular Meshwork

Iqbal Ike K. Ahmed, MD, FRCSC; Shamil Patel, MD; Mahmoud A. Khaimi, MD; Georges M. Durr, MD, FRCSC; and I. Paul Singh, MD

Spare or Tear? A Deep Dive on the Trabecular Meshwork

Iqbal Ike K. Ahmed, MD, FRCSC; Shamil Patel, MD; Georges M. Durr, MD, FRCSC; Mahmoud A. Khaimi, MD; and I. Paul Singh, MD

Back to All Videos

IGC 2024 Roundtable Discussion

Analisa Arosemena, MD; Rachel G. Simpson, MD; Larissa Camejo, MD; Shivani Kamat, MD; Mary Qiu, MD; Christine Funke, MD; and Sahar Bedrood, MD, PhD

Posted: 4/21/2025

Resources

Combined Canaloplasty and Cataract Surgery: Considerations for Implementation and Adoption

View Resource

The Opportunity in Canaloplasty

View Resource

Restoring the Anatomy with Canaloplasty

View Resource

Understanding the Mechanisms Associated With Canaloplasty

View Resource

Canaloplasty in a Case of Steroid-Induced Uncontrolled Ocular Hypertension image

Case Review: Canaloplasty in a Case of Steroid-Induced Uncontrolled Ocular Hypertension

View Resource

The Versatility of Standalone Canaloplasty

View Resource

Targeting and Treating All Glaucoma Anatomy with Canaloplasty

View Resource

Pros Versus Cons of Preserving Trabecular Meshwork in the Treatment of Glaucoma: Part 2

View Resource

Pros Versus Cons of Preserving Trabecular Meshwork in the Treatment of Glaucoma: Part 1

View Resource

About Nova Eye Medical

WE ARE NOVA EYE MEDICAL

With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.

Visit Us Online: nova-eye.com

Follow Nova Eye Medical

The Nova Eye iTrack™ Advance is indicated for fluid infusion or aspiration during surgery.

The Nova Eye iTrack™ Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.*

The Nova Eye iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma.

* The iTrack™ Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma.